Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Platelet BioGenesis

Platelet BioGenesis

A biotechnology company in Massachusetts that focuses on developing technology to produce donor-independent human platelets from human induced pluripotent stem cells.

Platelet BioGenesis is a biotechnology company in Massachusetts that focuses on developing technology to produce donor-independent human platelets from human induced pluripotent stem cells. Founded 2014 in Chestnut Hill, Massachusetts, United States by Jonathan Thon, Joseph Italiano, and Sven Karlsson, Platelet BioGenesis is a developer of human platelets from stem cells for therapeutic applications. The company's platelets are made using its patented microfluidic bioreactor that permits the production of mature blood cells, under controlled conditions, for transfusion therapy and replaces the need for a human platelet donor, enabling scaled platelet production to meet human clinical need, improved platelet purity to generate bacterial/viral-free and production of immune-compatible human platelets that are safer for human infusion. Platelet BioGenesis has assembled a team comprising experts in cell therapy, gene-editing, and platelet science.

Timeline

September 10, 2019
Platelet BioGenesis raises a $26,000,000 series A round from Ziff Capital Partners.
September 2019
Platelet BioGenesis raises a $26,000,000 series A round from Nest.Bio Ventures, QiMing Venture Partners, Qiming Venture Partners, Sculptor Capital Management, Ziff Capital Partners, eCoast Angel Network and eCoast Angels.
June 2017
Platelet BioGenesis raises a $10,000,000 series A round from Adena Partners I, L.P., QiMing Venture Partners, VI Ventures, Vivo Capital and eCoast Angels.
2014
Founded

Funding Rounds

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

References

Golden logo
By using this site, you agree to our Terms & Conditions.